Calcium Orotate Tablets — PCD Pharma Franchise, Manufacturers & Suppliers in India
Calcium Orotate Tablets
Calcium Orotate Tablets — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Opioid Antagonist / De-addiction Agent
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
<strong>Calcium Orotate Tablets</strong> is available from <strong>Trumac Healthcare</strong>, a WHO-GMP certified pharmaceutical manufacturer and supplier in India. This tablet formulation is offered on <strong>monopoly PCD pharma franchise</strong>, <strong>wholesale and distributor supply</strong>, and <strong>third party / contract manufacturing</strong> basis across all Indian states. We already manufacture Calcium Orotate across our existing range, so supply is established and lead times are short.
Therapeutic Indications
- Opioid overdose reversal (naloxone)
- Maintenance therapy in opioid use disorder (naltrexone)
- Maintenance of abstinence in alcohol use disorder
Mechanism of Action
Competitively blocks central opioid receptors (naloxone, naltrexone) or modulates glutamate–GABA neurotransmission (acamprosate), reducing reward signalling or craving.
Dosage & Administration
- Dosage of Calcium Orotate Tablets must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Acute withdrawal symptoms in opioid-dependent patients
- Nausea, GI upset
- Headache
- Insomnia
- Hepatic enzyme elevation (naltrexone)
Contraindications
- Current opioid dependence (naltrexone — without supervised withdrawal)
- Acute hepatitis or liver failure
- Hypersensitivity
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Calcium Orotate Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: <strong>Calcium Orotate Tablets</strong>. Trumac Healthcare supplies this addiction treatment with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Calcium Orotate Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Calcium Orotate Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Calcium Orotate Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
Is Calcium Orotate Tablet available for PCD pharma franchise on monopoly basis?
Yes. Calcium Orotate Tablets is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Calcium Orotate for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Calcium Orotate Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Calcium Orotate Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Calcium Orotate?
Calcium Orotate is classified as a Addiction Treatment — Opioid Antagonist / De-addiction Agent.
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Calcium Orotate Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Calcium Orotate Tablets?